Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Real-World Treatment Choices for AMD

(MedPage Today) -- Poor adherence to anti-VEGF therapy for neovascular age-related macular degeneration (nAMD) remains a major limitation of existing therapies, a review of a large clinical database showed. Almost 40% of patients stopped treatment...

Real-World Treatment Choices for AMD

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Wednesday 14 October →